LTFS
NVLN

Ladenburg Thalmann Financial Services’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-116
Closed – – 5700
2019
Q3 		$0 Hold
116
– – ﹤0.01% 5612
2019
Q2 		$0 Sell
116
-61
-34% -$68 ﹤0.01% 5551
2019
Q1 		$0 Hold
177
– – ﹤0.01% 5462
2018
Q4 		$0 Hold
177
– – ﹤0.01% 5459
2018
Q3 		$0 Hold
177
– – ﹤0.01% 5431
2018
Q2 		$0 Hold
177
– – ﹤0.01% 5199
2018
Q1 		$0 Hold
177
– – ﹤0.01% 5281
2017
Q4 		$0 Hold
177
– – ﹤0.01% 5193
2017
Q3 		$1K Sell
177
-40
-18% -$321 ﹤0.01% 4881
2017
Q2 		$2K Hold
217
– – ﹤0.01% 4662
2017
Q1 		$2K Hold
217
– – ﹤0.01% 4632
2016
Q4 		$2K Buy
+217
New +$1.92K ﹤0.01% 4587

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NVLN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 116 shares.

Ladenburg Thalmann Financial Services first reported a position in NVLN in Q4 2016 and held it in 12 quarters. The position peaked at $2K in Q2 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Ladenburg Thalmann Financial Services reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 116 Novelion Therapeutics Inc. Common Shares shares in Q4 2019.
  • Ladenburg Thalmann Financial Services first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 12 quarters.
  • Ladenburg Thalmann Financial Services's Novelion Therapeutics Inc. Common Shares position peaked at $2K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.